Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharma Value Will Surge On Number And Quality Of New Products – EvaluatePharma

This article was originally published in The Pink Sheet Daily

Executive Summary

EvaluatePharma’s 2013 industry portrait, released June 24 at the DIA annual meeting in Boston, predicts a rebound in pharma sales with near 4% growth out to 2018.

Advertisement

Related Content

An NME Surge After The Patent Cliff? Reinvention Of R&D Starts Paying Off In 2013 New Product Candidates
Are The 90s Back? Oncologics Drove FDA’s 2012 Novel Approval Count To 15-Year High

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS075880

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel